
Core Viewpoint - The article highlights the importance of Chinese listed companies engaging with international investors as a significant step in the opening of China's capital market, showcasing the investment value of companies in the Shenzhen Stock Exchange during an event in Singapore [1][2]. Group 1: International Engagement - The event in Singapore, organized by the Shenzhen Stock Exchange, featured companies like Mindray Medical, Inovance Technology, and others, emphasizing the achievements in China's new productive forces and the investment potential of these companies [1]. - International investors expressed a strong belief in the strategic significance and vast development opportunities of investing in the Chinese market, particularly in the context of increasing geopolitical uncertainties and tariff disputes [2]. Group 2: Globalization Progress - Shenzhen-listed companies are actively expanding their global presence by establishing sales offices and distribution channels, enhancing their roles in global competition [4]. - Companies like Megmeet, Teradyne, and Inovance Technology shared their successful experiences in overseas market expansion through localized operations and technological innovations, which have improved their global supply chain resilience [4]. Group 3: ESG and Carbon Reduction - A-share companies have made significant contributions to global carbon reduction through green technology innovations and sustainable development initiatives, showcasing strong competitiveness [6]. - Companies such as Mindray Medical and Inovance Technology have gained international recognition for their leading ESG management and carbon reduction technologies, with foreign investors particularly interested in their innovations in the renewable energy and environmental protection sectors [7][8]. Group 4: R&D Investment and Technological Barriers - High R&D investment has been a core driver for Chinese companies to overcome global competition barriers, with Shenzhen-listed companies projected to invest over 760 billion yuan in R&D in 2024 [10]. - The total number of effective patents held by Shenzhen-listed companies exceeds 10,000, with notable achievements in patent applications and technology breakthroughs, positioning them favorably in the global market [10]. - Investors are keen on the high R&D investments of Shenzhen companies, believing that continuous investment and exploration of AI applications will help these companies transition from "technology followers" to "standard setters" in emerging fields [10].